Tenders/AGREEMENT FOR THE SUPPLY OF INSULIN GLARGINE 100 IU ML DISPOSABLE PEN DRUG
Awarded🇨🇱ChileSuppliesThis tender has expired

AGREEMENT FOR THE SUPPLY OF INSULIN GLARGINE 100 IU ML DISPOSABLE PEN DRUG

Auto-translated from Spanish
Original title: Convenio suministro de fármaco de insulina glargina 100 ui ML lápiz desechable
Published: Mar 7, 2026
Updated: Jun 20, 2026
Source: chile_mercadopublico

This tender has been awarded

Awarded to INSTITUTO SANITAS S A — CLP 327,600,000

Browse open Health & Medical tenders in Chile

About This Opportunity

Translated

This tender concerns an agreement for the supply of Insulin Glargine 100 IU/mL in a disposable pen format. The procurement aims to secure a reliable source of this essential medication, which is a long-acting basal insulin used in the management of diabetes mellitus. The specific formulation required is 100 International Units per milliliter (IU/mL), delivered via a pre-filled, disposable pen device. This delivery system is designed for ease of use and accurate dosing, particularly beneficial for patients requiring consistent insulin therapy. The agreement will likely involve the provision of a specified quantity of this drug over a defined period, adhering to stringent quality standards and regulatory requirements for pharmaceutical products. Potential bidders are expected to demonstrate their capacity to supply high-quality Insulin Glargine, meet delivery timelines, and comply with all relevant national and international pharmaceutical regulations. The focus is on ensuring the availability of a critical therapeutic agent for patients managing their blood glucose levels. Further details regarding the scope of supply, technical specifications, delivery locations, and evaluation criteria will be provided in the full tender documentation. This procurement is crucial for maintaining adequate stock levels of this vital insulin analogue within the healthcare system.

This is a supplies contract in the health and medical services, transport and logistics and trade and industry sectors, with a focus on Pharmaceuticals, Logistics and Manufacturing. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Original language: Spanish

This tender, originating from Chile and accessible via the chile_mercadopublico platform, seeks to establish a supply agreement for a specific pharmaceutical product: insulin glargine 100 IU/mL in disposable pen devices. The contracting authority is looking to secure a reliable and consistent source for this essential medication.

The procurement is for a supply contract, indicating a need for ongoing provision rather than a one-time purchase. Suppliers are expected to demonstrate their capability to meet the required volumes and maintain product quality standards throughout the contract period. Typical requirements for such pharmaceutical tenders include adherence to stringent regulatory guidelines, such as those set by Chile's health authorities (e.g., ISP - Instituto de Salud Pública). Bidders will likely need to provide detailed product specifications, including information on manufacturing processes, quality control measures, and expiry dates. Furthermore, evidence of a robust supply chain, efficient logistics, and the ability to deliver to specified locations within Chile will be crucial. Experience in supplying similar pharmaceutical products to public or private healthcare providers, both domestically and internationally, may also be a significant consideration for evaluating potential suppliers. This tender represents an opportunity for pharmaceutical manufacturers and distributors to engage with the Chilean healthcare market and contribute to the availability of vital insulin therapy.

Data provenance

This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 26 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

INSTITUTO SANITAS S A was awarded the contract for CLP 327,600,000. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to INSTITUTO SANITAS S A. The award notice is archived on BidsFactory for transparency and market intelligence.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

Key Details

Submission Deadline
Mar 4, 2026
Deadline passed
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Spanish

Source

chile_mercadopublico
chile_mercadopublico
Official Source

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.